We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
-6.74%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$608M
AUM Growth
+$8.42M
(+1.4%)
Cap. Flow
+$70M
Cap. Flow
% of AUM
11.52%
Top 10 Holdings %
Top 10 Hldgs %
46.74%
Holding
185
New
59
Increased
29
Reduced
34
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sunrun
RUN
|
+$12.8M |
| 2 |
Atlassian
TEAM
|
+$10M |
| 3 |
NCR Voyix
VYX
|
+$7.08M |
| 4 |
Tenet Healthcare
THC
|
+$6.28M |
| 5 |
Wolfspeed
WOLF
|
+$6.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
|
+$21.1M |
| 2 |
Twilio
TWLO
|
+$12.2M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$10.1M |
| 4 |
B
Barrick Mining
B
|
+$7.36M |
| 5 |
Ambarella
AMBA
|
+$6.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Healthcare | 14.59% |
| 3 | Consumer Staples | 6.23% |
| 4 | Energy | 4.75% |
| 5 | Utilities | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
| $65.4M | 10.76% |
2,500,000
-750,000
| -23% | -$19.1M |
|
|
STKL
2
DELISTED
SunOpta
STKL
| $37.9M | 6.23% |
4,870,500
-434,500
| -8% | -$2.86M |
|
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $37.7M | 6.21% |
+100,000
| New | +$41M |
|
|
CTLP
4
DELISTED
Cantaloupe
CTLP
| $32.6M | 5.36% |
5,818,200
+611,700
| +12% | +$3.25M |
|
|
MBII
5
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $21.3M | 3.5% |
18,335,767
| – | – |
|
|
6
CALL
Sunrun
RUN
$2.3B
| $21M | 3.46% |
+900,000
| New | +$21.6M |
|
7
CALL
Invesco QQQ Trust
QQQ
$445B
| $21M | 3.46% |
+75,000
| New | +$23.3M |
|
|
8
Sunrun
RUN
$2.3B
| $16.3M | 2.68% |
697,000
+532,000
| +322% | +$12.8M |
|
9
Altimmune
ALT
$581M
| $15.7M | 2.58% |
1,339,000
-14,000
| -1% | -$86.3K |
|
10
STAAR Surgical
STAA
$1.13B
| $15.3M | 2.51% |
215,000
-46,450
| -18% | -$2.99M |
|
11
SolarEdge
SEDG
$2.44B
| $13.7M | 2.25% |
50,050
+20,050
| +67% | +$5.48M |
|
12
Vistra
VST
$50.1B
| $11.8M | 1.95% |
518,000
+90,500
| +21% | +$2.24M |
|
|
13
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $11.1M | 1.83% |
+150,000
| New | +$11.3M |
|
14
AstraZeneca
AZN
$267B
| $11M | 1.8% |
83,000
-7,500
| -8% | -$984K |
|
15
Surgery Partners
SGRY
$2.04B
| $10.1M | 1.67% |
350,000
+70,000
| +25% | +$3.06M |
|
|
16
Tenet Healthcare
THC
$22.6B
| $10M | 1.64% |
190,200
+90,200
| +90% | +$6.28M |
|
17
EOG Resources
EOG
$74.4B
| $9.43M | 1.55% |
85,300
+10,300
| +14% | +$1.28M |
|
|
AMPS
18
DELISTED
Altus Power
AMPS
| $9.05M | 1.49% |
1,435,000
+50,000
| +4% | +$334K |
|
|
19
Atlassian
TEAM
$25.4B
| $8.8M | 1.45% |
+46,900
| New | +$10M |
|
|
EVA
20
DELISTED
Enviva Inc.
EVA
| $8.58M | 1.41% |
150,000
-15,000
| -9% | -$1.13M |
|
21
PUT
Apple
AAPL
$4.99T
| $8.34M | 1.37% |
+61,000
| New | +$9.24M |
|
22
Pacira BioSciences
PCRX
$1.05B
| $7.87M | 1.3% |
135,000
+35,000
| +35% | +$2.29M |
|
23
Harmonic Inc
HLIT
$1.2B
| $7.6M | 1.25% |
876,500
-115,250
| -12% | -$1.04M |
|
|
24
Wolfspeed
WOLF
$1.14B
| $7.3M | 1.2% |
115,000
+75,000
| +188% | +$6.24M |
|
25
Dynatrace
DT
$12.7B
| $6.95M | 1.14% |
176,200
-35,800
| -17% | -$1.43M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Ardsley Advisory Partners held 185 positions worth $608M, up 1.4% from $599M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Ardsley Advisory Partners deployed $70M of net new capital in Q2 2022, opening 59 new positions and adding to 29 existing holdings. Its largest new stake was Atlassian: 46,900 shares worth $8.8M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Ambarella, an estimated $6.8M trimmed.
- Ardsley Advisory Partners's largest Q2 2022 buy was Atlassian: 46,900 shares worth $8.8M.
- Ardsley Advisory Partners added most to Sunrun in Q2 2022, an estimated $12.8M increase.
- Ardsley Advisory Partners's biggest Q2 2022 reduction was Ambarella, cutting an estimated $6.8M.
- Ardsley Advisory Partners fully exited ProShares Trust UltraShort Lehman 20+ Year Treasury in Q2 2022, selling an estimated $21.1M.
- Ardsley Advisory Partners's ten largest holdings make up 47% of its $608M portfolio in Q2 2022.
- Ardsley Advisory Partners opened 59 new positions and closed 61 in Q2 2022.
- Ardsley Advisory Partners's portfolio value rose 1.4% quarter-over-quarter to $608M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2022, filed 15 Aug 2022.